Short Report: Serum Levels of Neopterin during Antimicrobial Treatment for Mycobacterium ulcerans Infection
Standard
Short Report: Serum Levels of Neopterin during Antimicrobial Treatment for Mycobacterium ulcerans Infection. / de Zeeuw, Janine; Duggirala, Sridevi; Nienhuis, Willemien A; Abass, K Mohammed; Tuah, Wilson; Omansen, Till F.; van der Werf, Tjip S; Stienstra, Ymkje.
In: AM J TROP MED HYG, Vol. 89, No. 3, 09.2013, p. 498-500.Research output: SCORING: Contribution to journal › Other (editorial matter etc.) › Research
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Short Report: Serum Levels of Neopterin during Antimicrobial Treatment for Mycobacterium ulcerans Infection
AU - de Zeeuw, Janine
AU - Duggirala, Sridevi
AU - Nienhuis, Willemien A
AU - Abass, K Mohammed
AU - Tuah, Wilson
AU - Omansen, Till F.
AU - van der Werf, Tjip S
AU - Stienstra, Ymkje
PY - 2013/9
Y1 - 2013/9
N2 - Neopterin is closely associated with activation of the cellular immune system. Neopterin levels differed between controls and patients with Buruli ulcer disease. No differences between patients with or without paradoxical responses were observed. Therefore, neopterin has no value in detecting paradoxical responses among patients with limited Buruli ulcer disease. Neopterin levels were lower in patients receiving clarithromycin. This finding might indicate a slower cellular immune recovery, with possible consequences in future therapy with clarithromycin.
AB - Neopterin is closely associated with activation of the cellular immune system. Neopterin levels differed between controls and patients with Buruli ulcer disease. No differences between patients with or without paradoxical responses were observed. Therefore, neopterin has no value in detecting paradoxical responses among patients with limited Buruli ulcer disease. Neopterin levels were lower in patients receiving clarithromycin. This finding might indicate a slower cellular immune recovery, with possible consequences in future therapy with clarithromycin.
KW - Anti-Bacterial Agents/therapeutic use
KW - Buruli Ulcer/drug therapy
KW - Case-Control Studies
KW - Clarithromycin/therapeutic use
KW - Female
KW - Humans
KW - Male
KW - Mycobacterium ulcerans/drug effects
KW - Neopterin/blood
KW - Randomized Controlled Trials as Topic
KW - Time Factors
KW - Treatment Outcome
U2 - 10.4269/ajtmh.12-0599
DO - 10.4269/ajtmh.12-0599
M3 - Other (editorial matter etc.)
C2 - 23836576
VL - 89
SP - 498
EP - 500
JO - AM J TROP MED HYG
JF - AM J TROP MED HYG
SN - 0002-9637
IS - 3
ER -